Sponsored Videos

Factors to Consider in Filter Validation in Pharmaceutical QC

January 20th 2020

Case study to demonstrate sensitivity in Immunogenicity Assay should be based on result of both screening and Confirmatory tier

January 15th 2020

Quantitation of Biotherapeutics via LC-MS

January 14th 2020

Effect of Freeze Thaw Cycles of Conjugated Reagents on Immunogenicity Assays

January 10th 2020

Characterizing Deformation Properties of Directly Compressible Excipients using a Compaction Emulator

January 9th 2020

Early Drug Development Decision-Making Tips

January 7th 2020

Effects of Excipients on Skin Delivery of Drugs and Actives

January 6th 2020

Subcutaneous Drug Delivery

January 2nd 2020

Data as cGMP Records and Other Integrity Issues

August 14th 2019

Data Integrity Challenges

June 27th 2019

Maximizing the Effectiveness of Softgels Part 2

June 13th 2019

Maximizing the Effectiveness of Softgels Part 1

June 13th 2019

Sourcing APIs and Supply Chain Management

June 3rd 2019

Accelerating the Pathways to Biologics, Part 2

May 22nd 2019

Accelerating the Pathways to Biologics, Part 1

May 22nd 2019

Lipid Formulations for Drug Development

January 7th 2019

Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 3

January 3rd 2019

Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 2

January 3rd 2019

Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 1

January 3rd 2019

Strategies for Improving Preclinical Drug Development

December 17th 2018

Lonza AAPS Videos

December 14th 2018

Use of Extractables Data from Single-Use Components for Risk Assessments

September 4th 2018

Transforming Clinical Trials with Smart Technologies

August 20th 2018

Thought Leadership Series: Analytical Bioassay Cell Banking

July 19th 2018

ShinEtsu Video Page

April 3rd 2018

Catalent Dose Design

March 28th 2018

BASF Solubility Challenges

March 13th 2018

Thought Leadership Series: Solubilization

March 8th 2018

Catalent Small Molecule

March 2nd 2018

Catalent Early Development

March 2nd 2018

Sponsored Videos

Factors to Consider in Filter Validation in Pharmaceutical QC

Case study to demonstrate sensitivity in Immunogenicity Assay should be based on result of both screening and Confirmatory tier

Quantitation of Biotherapeutics via LC-MS

Effect of Freeze Thaw Cycles of Conjugated Reagents on Immunogenicity Assays

Characterizing Deformation Properties of Directly Compressible Excipients using a Compaction Emulator

Early Drug Development Decision-Making Tips

Effects of Excipients on Skin Delivery of Drugs and Actives

Subcutaneous Drug Delivery

Data as cGMP Records and Other Integrity Issues

Data Integrity Challenges

Maximizing the Effectiveness of Softgels Part 2

Maximizing the Effectiveness of Softgels Part 1

Sourcing APIs and Supply Chain Management

Accelerating the Pathways to Biologics, Part 2

Accelerating the Pathways to Biologics, Part 1

Lipid Formulations for Drug Development

Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 3

Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 2

Thought-Leadership Series Instant- and Modified-Release Dosage Forms, Part 1

Strategies for Improving Preclinical Drug Development

Lonza AAPS Videos

Use of Extractables Data from Single-Use Components for Risk Assessments

Transforming Clinical Trials with Smart Technologies

Thought Leadership Series: Analytical Bioassay Cell Banking

ShinEtsu Video Page

Catalent Dose Design

BASF Solubility Challenges

Thought Leadership Series: Solubilization

Catalent Small Molecule

Catalent Early Development

Trending on Pharmaceutical Technology

How the Critical Medicines Act Aims to Optimize European Pharma Competitiveness and Resilience

Kimberly-Clark to Buy Tylenol Maker Kenvue: Analyzing Risks and Rewards